Myomo (MYO) Tariff Resilience Score: 5/10 (As of Jul. 04, 2026)


MYO Myomo Inc MYO
55 GF Score
Price $1.03
GF Value $3.13
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Myomo Tariff Resilience Score?

Myomo MYO -0.96% 55 Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus rates MYO with a GF Score™ of 55/100 and a GF Value™ of $3.13 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Myomo ranks better than 79.21% on this metric.

Myomo has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Myomo has Myomo Inc's manufacturing is primarily in the US, but it imports components, exposing it to tariffs. Its sales are also US-focused, reducing export risks. Previous tariffs have impacted costs, but pricing power is limited.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Myomo might have Average Resilient.

Myomo  (AMEX:MYO) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Myomo Tariff Resilience Score Related Terms

MYO vs FOFA, ELUT, PAVM: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Myomo's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Myomo Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Myomo's Tariff Resilience Score falls into.


MYO
55GF Score
Myomo Inc MYO
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Myomo (MYO) has a Tariff Resilience Score of 5 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Myomo ranks #174 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is Myomo's Tariff Resilience Score too high?
Myomo's current Tariff Resilience Score is 5. Based on the distribution chart, Myomo ranks #174 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Myomo has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Myomo's Tariff Resilience Score compare to FOFA and ELUT?
According to the Medical Devices & Instruments industry distribution chart, Myomo ranks #174 out of 837 companies for Tariff Resilience Score. This places Myomo in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Myomo's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myomo stock overvalued right now?
Based on GuruFocus' analysis, Myomo (MYO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.13, compared to a current price of $1.03 — trading 67.1% below its estimated fair value. The current Tariff Resilience Score is 5. Myomo's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Myomo (MYO), the current Tariff Resilience Score is 5 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Myomo (MYO) Overvalued in 2026?

Based on GuruFocus' analysis, Myomo stock appears to be undervalued. The current stock price of $1.03 is trading 67.1% below its estimated GF Value™ of $3.13. GuruFocus considers Myomo to be Possible Value Trap.

Key valuation signals for MYO:

  • Tariff Resilience Score: 5
  • GF Value™: $3.13 vs. price of $1.03 (67.1% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the MYO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Myomo Business Description

Other Exchanges 0M61:Germany
Address 45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
55GF Score

Get the complete analysis for MYO

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.03
Price
$3.13
GF Value